This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Top Healthcare Picks: Teleflex (TFX), Privia Health Group (PRVA)

Tipranks - Fri May 8, 2:52PM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Teleflex (TFX) and Privia Health Group (PRVA) with bullish sentiments.

Claim 55% Off TipRanks

Teleflex (TFX)

Needham analyst Michael Matson maintained a Buy rating on Teleflex today and set a price target of $147.00. The company’s shares closed last Thursday at $132.22, close to its 52-week low of $128.55.

According to TipRanks.com, Matson is a 1-star analyst with an average return of -0.2% and a 42.4% success rate. Matson covers the Healthcare sector, focusing on stocks such as Insight Molecular Diagnostics, Establishment Labs Holdings, and Zimmer Biomet Holdings. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Teleflex with a $138.57 average price target.

See Insiders’ Hot Stocks on TipRanks >>

Privia Health Group (PRVA)

Needham analyst Matthew Shea reiterated a Buy rating on Privia Health Group today and set a price target of $30.00. The company’s shares closed last Thursday at $24.09.

According to TipRanks.com, Shea is a 1-star analyst with an average return of -4.3% and a 57.9% success rate. Shea covers the Healthcare sector, focusing on stocks such as Oncology Institute, Evolent Health, and Astrana Health. ;'>

Privia Health Group has an analyst consensus of Strong Buy, with a price target consensus of $31.54, representing a 37.3% upside. In a report issued on May 4, Canaccord Genuity also maintained a Buy rating on the stock with a $35.00 price target.

Read More on TFX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.